← brief for 2026-09-18 · Slowing decline

A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record

Key takeaways

A new study is starting to compare two diabetes drugs, empagliflozin and dapagliflozin. It will look at how well these drugs help people with kidney disease and heart failure. The study uses computer records to assign patients to groups. There are no results yet.

Who did this work

Run by Herlev and Gentofte Hospital.
Sites: Bispebjerg Hospital · Rigshospitalet · Herlev and Gentofte Hospital · Steno Diabetes Center Copenhagen · Nordsjællands Hospital · Holbæk Sygehus

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-09-18
https://clinicaltrials.gov/study/NCT06642272